These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33064272)

  • 21. [Predictive and Prognostic significance of high-sensitivity modified Glasgow Prognostic Score (HS-mGPS) in advanced gastric cancer patients treated with neoadjuvant chemotherapy].
    Cui Y; Li J; Cao YH; Liu MY; Shi ZX; Gao TH
    Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):195-200. PubMed ID: 28316218
    [No Abstract]   [Full Text] [Related]  

  • 22. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
    Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
    [No Abstract]   [Full Text] [Related]  

  • 23. The prognostic value of tumor budding in patients who had surgery for rectal cancer with and without neoadjuvant therapy.
    Şirin AH; Sökmen S; Ünlü SM; Ellidokuz H; Sarioğlu S
    Tech Coloproctol; 2019 Apr; 23(4):333-342. PubMed ID: 30900039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Total Neoadjuvant Therapy for Rectal Cancer in the CAO/ARO/AIO-12 Randomized Phase 2 Trial: Early Surrogate Endpoints Revisited.
    Diefenhardt M; Schlenska-Lange A; Kuhnt T; Kirste S; Piso P; Bechstein WO; Hildebrandt G; Ghadimi M; Hofheinz RD; Rödel C; Fokas E;
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.
    Sylvie L; Susanne B; Katja O
    Recent Results Cancer Res; 2012; 196():269-89. PubMed ID: 23129380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation.
    Shen L; Zhang H; Liang L; Li G; Fan M; Wu Y; Zhu J; Zhang Z
    Radiat Oncol; 2014 Dec; 9():295. PubMed ID: 25518933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method].
    Peng L; Yang W; Zhang Z; Zhi C; Zhou X; Liu H; Hua Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1148-1153. PubMed ID: 30370514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modified neoadjuvant rectal score as a novel prognostic model for rectal cancer patients who underwent chemoradiotherapy.
    Kawai K; Ozaki K; Nakano D; Dejima A; Ise I; Nakamori S; Kato H; Natsume S; Takao M; Yamaguchi T; Ishihara S
    Int J Clin Oncol; 2024 Jul; 29(7):1012-1018. PubMed ID: 38592641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of neoadjuvant concurrent chemoradiation on exosomal markers (CD63 and CD9) expression and their prognostic significance in patients with rectal adenocarcinoma.
    Khushman M; Prodduturvar P; Mneimneh W; Zotto VD; Akbar S; Grimm L; Rider P; Hunter J; Alkharabsheh O; Patel GK; Fabregas JC; Singh AP
    Oncotarget; 2021 Jul; 12(15):1490-1498. PubMed ID: 34316329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of KRAS status on tumor response and survival after neoadjuvant treatment of locally advanced rectal cancer.
    Zhou P; Goffredo P; Ginader T; Thompson D; Hrabe J; Gribovskaja-Rupp I; Kapadia M; Hassan I
    J Surg Oncol; 2021 Jan; 123(1):278-285. PubMed ID: 33022750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of platelet-associated biomarkers in rectal cancer patients received neoadjuvant chemoradiation: A retrospective study.
    Wang P; Wang Z; Liu Y; Xie J; Ren Y
    Cancer Radiother; 2021 Apr; 25(2):147-154. PubMed ID: 33423969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the Charlson Comorbidity Index a Prognostic Indicator for Toxicity and Mortality in Elderly Patients with Locally Advanced Rectal Cancer?
    Köstek O; Bozkaya Y; Hacıoğlu MB; Yıldırım Özdemir N; Yılmaz E; Demircan NC; Erdoğan B; Uzunoğlu S; Çiçin İ; Zengin N
    Arch Iran Med; 2019 May; 22(5):236-241. PubMed ID: 31256595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients.
    Belluco C; Forlin M; Delrio P; Rega D; Degiuli M; Sofia S; Olivieri M; Pucciarelli S; Zuin M; De Manzoni G; Di Leo A; Scabini S; Zorcolo L; Restivo A
    BMC Cancer; 2018 Nov; 18(1):1094. PubMed ID: 30419864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.
    Zuo ZG; Zhang XF; Wang H; Liu QZ; Ye XZ; Xu C; Wu XB; Cai JH; Zhou ZH; Li JL; Song HY; Luo ZQ; Li P; Ni SC; Jiang L
    Medicine (Baltimore); 2016 Mar; 95(9):e2988. PubMed ID: 26945418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
    Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
    [No Abstract]   [Full Text] [Related]  

  • 36. Is serum survivin expression a predictive biomarker in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy?
    Bozkaya Y; Özdemir NY; Sezer S; Köstek O; Demirci NS; Yazıcı O; Erdem GU; Eren T; Zengin N
    Cancer Biomark; 2018; 22(1):143-149. PubMed ID: 29562501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.
    Lorenzen S; Blank S; Lordick F; Siewert JR; Ott K
    Ann Surg Oncol; 2012 Jul; 19(7):2119-27. PubMed ID: 22395980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of Preoperative Plasma Fibrinogen and Neutrophil-to-Lymphocyte Ratio (the F-NLR Score) as a Prognostic Marker of Locally Advanced Rectal Cancer Following Preoperative Chemoradiotherapy.
    Sun Y; Zhang Y; Huang Z; Lin H; Lu X; Huang Y; Chi P
    World J Surg; 2020 Jun; 44(6):1975-1984. PubMed ID: 32020327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood neutrophil-lymphocyte ratio predicts survival in locally advanced cancer stomach treated with neoadjuvant chemotherapy FOLFOX 4.
    el Aziz LM
    Med Oncol; 2014 Dec; 31(12):311. PubMed ID: 25367855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of tumour regression grade in locally advanced rectal cancer: a systematic review and meta-analysis.
    Kong JC; Guerra GR; Warrier SK; Lynch AC; Michael M; Ngan SY; Phillips W; Ramsay G; Heriot AG
    Colorectal Dis; 2018 Jul; 20(7):574-585. PubMed ID: 29582537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.